Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
Moodys
Express Scripts
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 5,480,640

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,480,640
Title: Alpha interferon for treating prostate cancer
Abstract:Described is a method for treating carcinoma of the prostate using recombinant human alpha interferon via intraprostatic or intralesional injection.
Inventor(s): Morales; Alvaro (Kingston, CA), Wilson; James W. L. (Kingston, CA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/432,742
Patent Claims:see list of patent claims

Details for Patent 5,480,640

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Dow
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.